MyGenes, headquartered in Tel Aviv, Israel and London, England, is a leading nutrigenetics and research company changing the face of the nutrition world. Founded in 2016, our mission is to help people reach a healthy weight, balance blood sugar levels, improve sports performance, reduce the risk of metabolic disease, and be healthier, all without mental confusion, without discouraging diets, and with minimal effort. MyGenes uses groundbreaking technology to provide direct access to more than 425 genetic variants and personalized genetic-based nutrition and lifestyle recommendations, tailored menus, and the genetic match percentages for thousands of foods and recipes. In 2022, MyGenes published Israel’s first-ever nutrigenetics research, revealing how individuals can overcome genetic predispositions to obesity through targeted recommendations. In 2023, MyGenes launched FoodGenes, the world’s first algorithm that assesses an individual's genetic compatibility with foods to provide personalized match scores (0-100%) and recommendations of optimal food combinations based on unique genetic findings. We are proud to have been recognized as an Israel Innovator in 2023 by Menta magazine. More information is available at mygenes.co.il.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Igal Alon, Tel Aviv,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mygenes.co.uk/
- Keywords
- MyGene.
- HQ
- tel aviv
Mygenes Questions
Mygenes's website is https://www.mygenes.co.uk/
Mygenes's LinkedIn profile is https://il.linkedin.com/company/mygenesil
Mygenes has
23 employees.
View email and phone details for 23
employees at Mygenes.
Mygenes's industry is
Biotechnology Research
Mygenes's top competitors are
Immunai,
Moon Active,
Mygenes,
Cytoreason,
Mygeneself,
Mygene,
Amai Proteins,
Daytwo,
Compugen,
Protai.
Mygenes's categories are Biotechnology Research
Mygenes's founding year is 2016
